N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: A Valuable Endogenous Anti-Fibrotic Peptide for Combating Kidney Fibrosis in Diabetes

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2014.00070
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA